1 year return (CAGR)
53.11%
CytomX Therapeutics Inc Exchange (NASDAQ, USD)
CTMX
2.77
-0.09 (-2.74%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
32.36%
5 year return (CAGR)
-9.04%
10 year return (CAGR)
-12.17%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
697.28M
Price/Sales
38.10
Ent value
759.21M
Price/Book
2.31
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-3.63%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-29.30%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.30 |
| Daily high | 3.36 |
| Daily low | 3.15 |
| Daily Volume | 6.14M |
| All-time high | 34.22 |
| 1y analyst estimate | 12.25 |
| Beta | 2.14 |
| EPS (TTM) | -0.36 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| CTMX | S&P500 | |
| Current price drop from All-time high | -91.92% | -3.06% |
| Highest price drop | -98.74% | -56.47% |
| Date of highest drop | 7 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -71.13% | -10.68% |
| Avg time to new high | 79 days | 12 days |
| Max time to new high | 2139 days | 1805 days |
News
